The Treatment Paradigm Shifts Again on Prostate Cancer

被引：5

作者：

Albertsen, Peter C. ^{[1
]}

机构：

[1] Univ Connecticut, Ctr Hlth, Div Urol, Farmington, CT 06030 USA

来源：

EUROPEAN UROLOGY | 2009年 / 55卷 / 01期

关键词：

RADICAL PROSTATECTOMY; ACTIVE SURVEILLANCE; MEN; VALIDATION;

D O I：

10.1016/j.eururo.2008.09.014

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：9 / 13

页数：5

共 18 条

[1] 20-year outcomes following conservative management of clinically localized prostate cancer [J].

Albertsen, PC ;

Hanley, JA ;

Fine, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17) :2095-2101

[2]

ALBERTSEN PC, 2003, J NATL CANCER I, V95, P868

[3] The Treatment Paradigm Shifts Again on Prostate Cancer [J].

Albertsen, Peter C. .

EUROPEAN UROLOGY, 2009, 55 (01) :9-13

[4] Radical prostatectomy versus watchful waiting in early prostate cancer [J].

Bill-Axelson, A ;

Holmberg, L ;

Ruutu, M ;

Häggman, M ;

Andersson, SO ;

Bratell, S ;

Spångberg, A ;

Busch, C ;

Nordling, S ;

Garmo, H ;

Palmgren, J ;

Adami, HO ;

Norlén, BJ ;

Johansson, JE .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (19) :1977-1984

[5] Radical prostatectomy versus watchful waiting in localized prostate cancer:: the Scandinavian Prostate Cancer Group-4 randomized trial [J].

Bill-Axelson, Anna ;

Holmberg, Lars ;

Filen, Frej ;

Ruutu, Mirja ;

Garmo, Hans ;

Busch, Christer ;

Nordling, Stig ;

Haggman, Michael ;

Andersson, Swen-Olof ;

Bratell, Stefan ;

Spangberg, Anders ;

Palmgren, Juni ;

Adami, Hans-Olov ;

Johansson, Jan-Erik .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (16) :1144-1154

[6] How much does Gleason grade of follow-up biopsy differ from that of initial biopsy in untreated, Gleason score 4-7, clinically localized prostate cancer? [J].

Choo, R. ;

Danjoux, C. ;

Morton, G. ;

Szumacher, E. ;

Sugar, L. ;

Gardner, S. ;

Kim, M. ;

Choo, C. M. ;

Klotz, L. .

PROSTATE, 2007, 67 (15) :1614-1620

[7] Quality improvement report - Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study [J].

Donovan, J ;

Mills, N ;

Smith, M ;

Brindle, L ;

Jacoby, A ;

Peters, T ;

Frankel, S ;

Neal, D ;

Hamdy, F .

BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7367) :766-769

[8] Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer [J].

Draisma, G ;

Boer, R ;

Otto, SJ ;

van der Cruijsen, IW ;

Damhuis, RAM ;

Schröder, FH ;

de Koning, HJ .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) :868-878

[9] Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era [J].

Ercole, Barbara ;

Marietti, Sarah R. ;

Fine, Judith ;

Albertsen, Peter C. .

JOURNAL OF UROLOGY, 2008, 180 (04) :1336-1339

[10] Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004 [J].

Hussain, Sabina ;

Gunnell, David ;

Donovan, Jenny ;

McPhail, Sean ;

Hamdy, Freddie ;

Neal, David ;

Albertsen, Peter ;

Verne, Julia ;

Stephens, Peter ;

Trotter, Caroline ;

Martin, Richard M. .

BJU INTERNATIONAL, 2008, 101 (05) :547-555

← 1 2 →